724-P: Implementing an Early Type 1 Diabetes Clinic and Immunotherapy Treatment Program for Patients with Stage 1 and Stage 2 Type 1 Diabetes

Introduction Provention Bio, Inc. Consultant; Provention Bio, Inc. Research Support; Provention Bio, Inc., Novartis AG. Consultant; Medtronic. L. Chesshir: None. H.K. O'Donnell: None. S.C. Walker: Other Relationship; Dexcom, Inc., Insulet Corporation. A.D. Martinez: None. G.T. Alonso: Advisory Panel; MannKind Corporation. T.M. Triolo: None. P. Gottlieb: Other Relationship; IM Therapeutics. Research Support; Imcyse. Advisory Panel; Imcyse. Consultant; Juvenile Diabetes Research Foundation (JDRF). Research Support; Hemsley Charitable Trust, Novartis AG, Provention Bio, Inc., Precigen, Inc. Advisory Panel; ViaCyte, Inc. Research Support; Nova Pharmaceuticals. B.I. Frohnert: None. A. Steck: None.